IDO1 and urinary bladder carcinoma: Despite the bulk of evidence supporting a role for IDO1 in promoting tumor formation and tumor immune escape, there have been clinical studies showing an anti-tumor effect of IDO1 by the intermediate of IFN-γ, which was effective in the therapy of ovarian carcinoma and bladder cancer [67,68,69].